Cargando…
Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse
BACKGROUND: We aim to assess the long-term efficacy of transvaginal high uterosacral ligament suspension (HUS) procedure for middle compartment defect-based pelvic organ prolapse (POP). METHODS: We performed a retrospective review of 84 women with middle-compartment defect-based POP who underwent tr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812174/ https://www.ncbi.nlm.nih.gov/pubmed/33490157 http://dx.doi.org/10.21037/atm-20-7296 |
_version_ | 1783637611944869888 |
---|---|
author | Wang, Wenying Zhang, Yinghui Shen, Wenjie Niu, Ke Lu, Yongxian |
author_facet | Wang, Wenying Zhang, Yinghui Shen, Wenjie Niu, Ke Lu, Yongxian |
author_sort | Wang, Wenying |
collection | PubMed |
description | BACKGROUND: We aim to assess the long-term efficacy of transvaginal high uterosacral ligament suspension (HUS) procedure for middle compartment defect-based pelvic organ prolapse (POP). METHODS: We performed a retrospective review of 84 women with middle-compartment defect-based POP who underwent transvaginal HUS as the primary surgical treatment without mesh augmentation from January 2007 to January 2019. All 84 patients manifested ≥ grade-II middle-compartment defect-based POP. Follow-up visits were performed 2, 6 and 12 months after surgery and then annually, including questionnaires and clinical examination using pelvic organ prolapse quantitation system (POP-Q). Surgical success required to fulfill all three of these criteria: (I) anterior or posterior vaginal wall prolapsed the leading edge of 0 cm or less and apex of 1/2 total vaginal length or less; (II) the absence of POP symptoms as reported on the PFDI-20 question No. 3 (“do you usually have a bulge or something falling out that you can see or feel in your vaginal area?”); and (III) no prolapse re-operations or pessary use during the study period. RESULTS: Of 84 women, 56 cases (66.7%, 56/84) were evaluated at a ≥5-year follow-up. The 5-year recurrence rates for patients with prolapse of either the anterior vaginal wall, vaginal vault, or posterior vaginal wall, or prolapses in multiple sites, were 7.1% (4/56), 0, 1.8% (1/56), and 3.6% (2/56), respectively. The surgery success rate was 87.5% (49/56). None of the recurrent women underwent retreatment. The satisfaction rate was 91.1% (51/56). CONCLUSIONS: Transvaginal HUS without mesh augmentation is a safe and effective procedure in the surgical treatment of patients with middle-compartment defects. Anatomical, functional, and subjective outcomes were very satisfactory. |
format | Online Article Text |
id | pubmed-7812174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-78121742021-01-22 Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse Wang, Wenying Zhang, Yinghui Shen, Wenjie Niu, Ke Lu, Yongxian Ann Transl Med Original Article BACKGROUND: We aim to assess the long-term efficacy of transvaginal high uterosacral ligament suspension (HUS) procedure for middle compartment defect-based pelvic organ prolapse (POP). METHODS: We performed a retrospective review of 84 women with middle-compartment defect-based POP who underwent transvaginal HUS as the primary surgical treatment without mesh augmentation from January 2007 to January 2019. All 84 patients manifested ≥ grade-II middle-compartment defect-based POP. Follow-up visits were performed 2, 6 and 12 months after surgery and then annually, including questionnaires and clinical examination using pelvic organ prolapse quantitation system (POP-Q). Surgical success required to fulfill all three of these criteria: (I) anterior or posterior vaginal wall prolapsed the leading edge of 0 cm or less and apex of 1/2 total vaginal length or less; (II) the absence of POP symptoms as reported on the PFDI-20 question No. 3 (“do you usually have a bulge or something falling out that you can see or feel in your vaginal area?”); and (III) no prolapse re-operations or pessary use during the study period. RESULTS: Of 84 women, 56 cases (66.7%, 56/84) were evaluated at a ≥5-year follow-up. The 5-year recurrence rates for patients with prolapse of either the anterior vaginal wall, vaginal vault, or posterior vaginal wall, or prolapses in multiple sites, were 7.1% (4/56), 0, 1.8% (1/56), and 3.6% (2/56), respectively. The surgery success rate was 87.5% (49/56). None of the recurrent women underwent retreatment. The satisfaction rate was 91.1% (51/56). CONCLUSIONS: Transvaginal HUS without mesh augmentation is a safe and effective procedure in the surgical treatment of patients with middle-compartment defects. Anatomical, functional, and subjective outcomes were very satisfactory. AME Publishing Company 2020-12 /pmc/articles/PMC7812174/ /pubmed/33490157 http://dx.doi.org/10.21037/atm-20-7296 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Wang, Wenying Zhang, Yinghui Shen, Wenjie Niu, Ke Lu, Yongxian Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse |
title | Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse |
title_full | Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse |
title_fullStr | Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse |
title_full_unstemmed | Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse |
title_short | Long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse |
title_sort | long-term efficacy of transvaginal high uterosacral ligament suspension for middle-compartment defect-based pelvic organ prolapse |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812174/ https://www.ncbi.nlm.nih.gov/pubmed/33490157 http://dx.doi.org/10.21037/atm-20-7296 |
work_keys_str_mv | AT wangwenying longtermefficacyoftransvaginalhighuterosacralligamentsuspensionformiddlecompartmentdefectbasedpelvicorganprolapse AT zhangyinghui longtermefficacyoftransvaginalhighuterosacralligamentsuspensionformiddlecompartmentdefectbasedpelvicorganprolapse AT shenwenjie longtermefficacyoftransvaginalhighuterosacralligamentsuspensionformiddlecompartmentdefectbasedpelvicorganprolapse AT niuke longtermefficacyoftransvaginalhighuterosacralligamentsuspensionformiddlecompartmentdefectbasedpelvicorganprolapse AT luyongxian longtermefficacyoftransvaginalhighuterosacralligamentsuspensionformiddlecompartmentdefectbasedpelvicorganprolapse |